SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
198 hedge funds and large institutions have $411M invested in Sage Therapeutics in 2025 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 50 increasing their positions, 53 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
198
Holders Change
+22
Holders Change %
+12.5%
% of All Funds
2.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
60
Increased
50
Reduced
53
Closed
37
Calls
$2.1M
Puts
$2.63M
Net Calls
-$526K
Net Calls Change
-$2.17M
Top Buyers
| 1 |
MAP
Madison Avenue Partners
New York
|
$35.6M |
| 2 |
TAL
TIG Advisors LLC
New York
|
$21.7M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$16.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$14M |
| 5 |
D.E. Shaw & Co
New York
|
$16.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$65.7K |
| 2 |
Morgan Stanley
New York
|
$11.1M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$0 |
| 4 |
RI
RTW Investments
New York
|
$0 |
| 5 |
Millennium Management
New York
|
$2.46M |
